News | Careers |Contact
Global

Event Recap | Great Bay Bio Co-Hosts Two Forums at BioCMC 2026

2026-10-27


The 10th BioCMC Conference on Innovation and Industrialization of Biopharmaceutical CMC, hosted by Baise Media, recently concluded successfully in Suzhou, China. Great Bay Bio co-hosted two forums at the conference: the Biologics Early Development & AI Forum and the Protein Drug Process Development Forum. The events brought together industry experts, corporate representatives, and fellow professionals to explore cutting-edge technologies and innovative practices in biologics research and process development.


Across the two forums, Great Bay Bio delivered presentations on AI-driven early-stage development of biologics and site-specific integration for cell line development, sharing insights into the company's technological advances and practical approaches to intelligent drug discovery and cell line development.





AI-Driven Early Development | Exploring New Paradigms in Biologics Development





At the Biologics Early Development & AI Forum, Dr. Michael Chen, Co-founder and CEO of Great Bay Bio, delivered a presentation titled “Biologics Development Paradigms: From Traditional Workflows to AI-Driven Drug Development.”

Dr. Chen discussed the application of AI in biologics development and explored the transition from traditional workflows to data-driven, intelligent development models. He also examined the potential of AI in molecular design, candidate molecule screening, and R&D decision-making, offering new perspectives on improving early-stage development efficiency and enhancing coordination across R&D workflows.

Protein Drug Process Development | Advancing Cell Line Development Through Site-Specific Integration




At the Protein Drug Process Development Forum, Dr. Kane Qi, Chief Business Officer of Great Bay Bio, delivered a presentation titled “AlfaCell Site-Specific Integration Platform: Redefining Workflows, Risks, and Organizational Models in Biologics Cell Line Development.”

Dr. Qi introduced the technological approach and application value of AlfaCell, Great Bay Bio's site-specific integration platform for cell line development. His presentation explored workflow optimization, critical risk management, and innovative R&D organizational models, highlighting how site-specific integration strategies can improve the controllability and predictability of cell line development and support the efficient advancement of biologics programs.


As a co-organizer of the two forums at BioCMC 2026, Great Bay Bio continues to advance site-specific integration technologies for cell line development while exploring the integration of AI into biologics R&D. Looking ahead, Great Bay Bio will continue to drive innovation and platform advancement, collaborate with industry partners to promote the development and application of site-specific integration technologies, and facilitate more efficient biologics R&D and the translation of innovative discoveries into practical outcomes—contributing to the high-quality development of the biopharmaceutical industry.



Back
Recent News
Platform Case Study | Fat Loss Without Muscle Loss: AlfaDAX Powers End-to-End ActRII Antibody Development, with Research Findings Published on bioRxiv

Platform Case Study | Fat Loss Without Muscle Loss: AlfaDAX Powers End-to-End ActRII Antibody Development, with Research Findings Published on bioRxiv

2026-09-04
Accepted for Both Oral Presentation and Poster! Two Great Bay Bio Technology Advancements Enabling Antibody R&D for Obesity Targets Selected for Obesity Week® 2026

Accepted for Both Oral Presentation and Poster! Two Great Bay Bio Technology Advancements Enabling Antibody R&D for Obesity Targets Selected for Obesity Week® 2026

2026-08-12
AlfaCell Platform Enables Client’s Out-Licensed Pipeline to Successfully Enter Phase II Clinical Trials, Advancing Novel Drugs and Biosimilars in Parallel

AlfaCell Platform Enables Client’s Out-Licensed Pipeline to Successfully Enter Phase II Clinical Trials, Advancing Novel Drugs and Biosimilars in Parallel

2026-08-07
Global Bioprocessing Made Simpler and More Efficient
Schedule a Meeting

Schedule a Meeting

I agree to the privacy policy.

Submit
COPYRIGHT 2026 © Great Bay Bio ALL RIGHTS RESERVD.